During the past decade, Aurora Cancer Care-Burlington conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aurora Cancer Care-Burlington" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Aurora Cancer Care-Burlington" are "Advanced Solid Tumors" (1 trials), "Colorectal Cancer" (1 trials), "High Grade Upper Tract Urothelial Carcinoma" (1 trials), "Kidney Cancer" (1 trials) and "Lymphoma, Non-Hodgkin" (1 trials). Many other conditions were trialed in "Aurora Cancer Care-Burlington" in a lesser frequency.

Most popular intervention types in "Aurora Cancer Care-Burlington" are "Drug" (4 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (2 trials), "5-fluorouracil" (1 trials), "Abemaciclib" (1 trials), "Atezolizumab and PHESGO" (1 trials) and "Atezolizumab and Talazoparib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aurora Cancer Care-Burlington" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Aurora Cancer Care-Burlington". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Aurora Cancer Care-Burlington, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Aurora Cancer Care-Burlington, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".